Gene Therapy Global Market Opportunities And Strategies To 2032

Gene Therapy Market 2023 – By Gene Therapy Type (Germline Therapy, Somatic Cell Therapy), By Vector (Viral Vector, Non-Viral Vector), By End Users (Biopharmaceutical Companies, Research Institutes, Other End Users), By Application (Oncology, Orphan Disease, Knee Osteoarthritis, Neurological Disorders), And By Region, Opportunities And Strategies – Global Forecast To 2032

Name: Gene Therapy Global Market Opportunities And Strategies To 2032
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Gene Therapy Global Market Opportunities And Strategies To 2032

Starting Price : $5000.00 $3500.00 | Pages : 305 | Published : May 2023 | | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Proud Members Of

Gene Therapy Market Definition

Gene therapy is a medical technique that involves introducing or modifying genes within an individual's cells to treat or prevent disease. It aims to correct or replace faulty genes responsible for disease development, restore or enhance the function of normal genes, or introduce new genes to produce therapeutic proteins that can fight or prevent diseases.

The gene therapy market consists of sales, by entities (organizations, sole traders and partnerships), of gene therapy products that are used to treat and prevent disease. It works by introducing an engineered gene into the cells of the patient. Gene therapy products are biological products.

Book your 30 minutes free consultation with our research experts

Gene Therapy Market Size

The global gene therapy market reached a value of nearly $7,370.8 million in 2022, having increased at a compound annual growth rate (CAGR) of 15.8% since 2017. The market is expected to grow from $7,370.8 million in 2022 to $24,027.1 million in 2027 at a rate of 26.7%. The market is then expected to grow at a CAGR of 13.4% from 2027 and reach $45,071.9 million in 2032.

Growth in the historic period resulted from rising pharmaceutical R&D expenditure, a rise in public-private partnerships, government investments and rising cases of spinal muscular atrophy. Factors that negatively affected growth in the historic period were off-target specificity, challenges in nucleotide delivery to cells, instability of the nucleotides, challenges due to regulatory changes, low healthcare access, reimbursement challenges and the coronavirus pandemic.

Going forward, an increasing number of cancer cases, a growing aging population, increasing research and development spending in the pharmaceutical sector and a rising focus on gene therapy will drive the market. Factors that could hinder the growth of the gene therapy market in the future include high cost of gene therapy, stringent regulations and the Russia- Ukraine war.

Gene Therapy Market Drivers

The key drivers of the gene therapy market include:

Increasing Number Cancer Cases

Increasing number of cancer cases is expected to drive the growth of the gene therapy market during the forecast period. Cancer gene therapy is an emerging field using genetic material to modify cells in vitro or in vivo to help effect a cure. In gene therapy, a therapeutic human-designed new gene (transgene) was used to introduce to a subpopulation of human cells, such as human stem cells. For a cancer cell, the transgene can assist cell death or restore normal cellular functions, whereas for normal cells the transgene can protect them from drug-induced side effects and/or cytotoxicity. For example, according to the American Cancer Society, a US-based voluntary health organization, a total of 1.9 million new cancer cases and 609,360 deaths from cancer were expected to occur in the USA in 2022, which is about 1,670 deaths a day. Additionally, according to the International Agency for Research on Cancer, a France-based intergovernmental agency, by 2040, the number of new cancer cases per year globally is expected to rise to 29.5 million and the number of cancer-related deaths to 16.4 million. Therefore, the increase in the number of cases of cancer is expected to contribute to the growth of the gene therapy market going forward.

Gene Therapy Market Restraints

The key restraints on the gene therapy market include:

High Cost Of Gene Therapy

High cost of gene therapy is expected to limit the growth of the gene therapy market during the forecast period. The manufacturing and drug development costs have a big impact on the price tags of gene therapy. Depending on the disease, raw materials used in gene therapy can be expensive. In less wealthy countries, the lack of cost-effective therapies for cancer and other diseases has influenced the health conditions of the population and led to a low average life expectancy. For example, Skysona, a treatment for a rare neurological disorder, launched at $3 million in September 2022. Additionally, in August 2022, Zynteglo, a gene therapy for a genetic blood disorder launched at $2.8 million. Therefore, the high cost of gene therapy will restrict the growth of the gene therapy market.

Gene Therapy Market Trends

Major trends influencing the gene therapy market include:

Growing Investments and Manufacturing Facility Expansion

Gene therapy manufacturers are progressively investing in the launch of new manufacturing facilities and product portfolio expansion to meet the increasing demand for gene therapies and related products. For example, in June 2022, REGENXBIO, a US based clinical-stage biotechnology company, announced the opening of its new manufacturing innovation center for gene therapy manufacturing in Rockville, Md. The company has invested $65 million to enable end-to-end control of gene therapy manufacturing at the center. Further, in September 2021, Viralgen, a Bayer-owned CDMO, spent upwards of €50 million ($ 55 million) to expand its capacity for gene therapy manufacturing services at its Miramon Technology Park site in San Sebastian, Spain. The commercial facility will have nine cleanrooms, each with a batch capacity of up to 2,000 L. Viralgen claims that this has expanded its existing viral vector capacity 15-fold, helping to meet the demand for gene therapy production.

Use Of Tetracycline-Enabled Self-Silencing Adenovirus (TESSA) Technology

Companies in the market are increasingly focusing on Tetracycline-Enabled Self-Silencing Adenovirus (TESSA) technology to improve gene therapy production. TESSA technology is a plasmid-free, scalable AAV (adeno-associated virus) manufacturing system. TESSA vectors are adenoviral vectors engineered such that they still provide high-quality help for AAV production but cannot produce adenoviral structural proteins, and eliminates contamination. For example, in March 2022, WuXi AppTec’s wholly-owned subsidiary WuXi Advanced Therapies (WuXi ATU), a US-based integrated contract testing development and manufacturing organization, announced the launch of Tetracycline-Enabled Self-Silencing Adenovirus (TESSA) technology to improve scalability and accessibility of cell and gene therapies. The new technology, which is developed by Oxgene, a UK-based biotechnology company offers a scalable process to manufacture gene therapies. It also helps to accelerate the production of therapeutic DNA required for the treatment of patients in need. The technology will expedite the manufacturing of adeno-associated virus (AAV) and reduce the costs to produce cell and gene therapies and they will allow its global customers to develop and deliver accessible therapies for patients as quickly as possible.

Opportunities And Recommendations In The Gene Therapy Market

Opportunities –The top opportunities in the gene therapy market by vector will arise in the viral vector market, which will gain $14,868.9 million of global annual sales by 2027. The top opportunities in the gene therapy market by application will arise in the oncology market, which will gain $7,080.0 million of global annual sales by 2027. The top opportunities in the gene therapy market by end users will arise in the biopharmaceutical companies market, which will gain $8,883.0 million of global annual sales by 2027. The top opportunities in the gene therapy market by gene therapy will arise in the somatic cell therapy market, which will gain $15,839.6 million of global annual sales by 2027. The gene therapy market size will gain the most in the USA at $4,612.0 million.

Recommendations-To take advantage of the opportunities, The Business Research Company recommends the gene therapy companies to focus on investments in manufacturing facility expansion, focus on use of tetracycline-enabled self-silencing adenovirus (TESSA) technology, increase focus on gene editing, expand in emerging markets, continue to focus on developed markets, focus on partnerships and collaborations, focus on mergers and acquisitions, provide competitively priced offerings, participate in trade shows and events, continue to use B2B promotions, continue to target fast-growing end-users , and focus on fast-growing applications.

Gene Therapy Market Segmentation

The gene therapy market is segmented by gene therapy type, by vector, by end users and by application.
By Gene Therapy Type -
The gene therapy market is segmented by gene therapy type into

a) Germline Therapy
b) Somatic Cell Therapy

The somatic cell therapy was the largest segment of the gene therapy market by gene therapy type, accounting for $7,002.2 million or 95.0% of the total market in 2022. It is expected to be the fastest-growing segment going forward at a CAGR of 26.7%.
By Vector -
The gene therapy market is segmented by vector into

a) Viral Vector
b) Non-Viral Vector

The viral vector was the largest segment of the gene therapy market by vector, accounting for $6,555.7 million or 88.9% of the total market in 2022. It is expected to be the fastest-growing segment going forward at a CAGR of 26.7%.
By End Users -
The gene therapy market is segmented by end users into

a) Biopharmaceutical Companies
b) Research Institutes
c) Other End Users

The biopharmaceutical companies was the largest segment of the gene therapy market by end users, accounting for $3,882.7 million or 52.7% of the total market in 2022. The other end users market is expected to be the fastest-growing segment going forward at a CAGR of 27.6%.
By Application -
The gene therapy market is segmented by application into

a) Oncology
b) Orphan Disease
c) Knee Osteoarthritis
d) Neurological Disorders

The oncology market was the largest segment of the gene therapy market by application, accounting for $3,258.2 million or 44.2% of the total market in 2022. The neurological disorders market is expected to be the fastest-growing segment going forward at a CAGR of 27.7%.
By Geography - The gene therapy market is segmented by geography into

• China
• India
• Japan
• Australia
• Indonesia
• South Korea

• USA

• Brazil

• France
• Germany
• UK

• Russia

North America was the largest region in the gene therapy market, accounting for 44.6% of the global market in 2022. It was followed by Western Europe, Asia Pacific and the other regions. Going forward, the fastest growing regions in the gene therapy market will be South America and the Middle East, where growth will be at CAGRs of 44.4% and 42.3% respectively from 2022-2027.

Gene Therapy Market Competitive Landscape

Major Competitors are:

Novartis AG

F. Hoffmann-La Roche Ltd

Gilead Sciences Inc.

Astellas Pharma Inc.

Biogen Inc.

Other Competitors Include:

UniQure NV

REGENXBIO Inc.

Bristol-Myers Squibb

BioMarin Pharmaceuticals Inc.

Jazz Pharmaceuticals Inc.

Biocon

Cipla

EdiGene Inc

Takara Bio

Daiichi Sankyo Company

Mitsubishi Tanabe Pharma

Merck

GE Healthcare

Lonza

Pfizer

Cellular Biomedicine Group

GenScript

Albumedix Ltd

Catalent

Freeline Therapeutics

DiNAQOR AG

Vivet Therapeutics

Allergan

Takeda Pharmaceutical

Amgen

Biocad

Celgene Corporation

Johnson & Johnson

Eli Lilly and Company

AstraZeneca

Bayer AG

Juno Therapeutics

Allogene Therapeutics

Bluebird Bio

Regen BioPharma

Bellicum

Amgen Brasil

GlaxoSmithKline plc

Biogen Brazil

Biotchpharma

BrainStorm Cell Therapeutics

Pluristem

Sanofi

Bayer East Africa Ltd

1. Executive Summary

2. Table Of Contents

3. List Of Figures

4. List Of Tables

5. Report Structure

6. Introduction And Market Characteristics

6.1. General Market Definition

6.2. Summary

6.3. Gene Therapy Market Definition And Segmentations

6.4. Market Segmentation By Gene Therapy Type

6.4.1. Germline Therapy

6.4.2. Somatic Cell Therapy

6.5. Market Segmentation By Vector

6.5.1. Viral Vector

6.5.2. Non-Viral Vector

6.6. Market Segmentation By End Users

6.6.1. Biopharmaceutical Companies

6.6.2. Research Institutes

6.6.3. Other End Users

6.7. Market Segmentation By Application

6.7.1. Oncology

6.7.2. Orphan Disease

6.7.3. Knee Osteoarthritis

6.7.4. Neurological Disorders

7. Major Market Trends

7.1. Growing Investments and Manufacturing Facility Expansion

7.2. Use Of Tetracycline-Enabled Self-Silencing Adenovirus (TESSA) Technology

7.3. Launch Of Cell And Gene Therapy Platforms

7.4. Partnerships And Collaborations

7.5. Rising Focus On Gene Editing

7.6. Strategic Mergers And Acquisitions

8. Global Market Size and Growth

8.1. Market Size

8.2. Historic Market Growth, 2017 – 2022, Value ($ Million)

8.2.1. Market Drivers 2017 – 2022

8.2.2. Market Restraints 2017 – 2022

8.3. Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

8.3.1. Market Drivers 2022 – 2027

8.3.2. Market Restraints 2022 – 2027

9. Global Gene Therapy Market Segmentation

9.1. Global Gene Therapy Market, Segmentation By Gene Therapy Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

9.2. Global Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

9.3. Global Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

9.4. Global Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

10. Gene Therapy Market, Regional and Country Analysis

10.1. Global Gene Therapy Market, By Region, Historic and Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

10.2. Global Gene Therapy Market, By Country, Historic and Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

11. Asia-Pacific Market

11.1. Summary

11.2. Market Overview

11.2.1. Region Information

11.2.2. Market Information

11.2.3. Background Information

11.2.4. Government Initiatives

11.2.5. Regulations

11.2.6. Regulatory Bodies

11.2.7. Major Associations

11.2.8. Taxes Levied

11.2.9. Corporate Tax Structure

11.2.10. Investments

11.2.11. Major Companies

11.3. Asia-Pacific Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

11.4. Asia-Pacific Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

11.5. Asia-Pacific Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

11.6. Asia-Pacific Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

11.7. Asia-Pacific Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

11.8. Asia-Pacific Gene Therapy Market: Country Analysis

11.9. China Market

11.10. Summary

11.11. Market Overview

11.11.1. Country Information

11.11.2. Market Information

11.11.3. Background Information

11.11.4. Government Initiatives

11.11.5. Regulations

11.11.6. Regulatory Bodies

11.11.7. Major Associations

11.11.8. Taxes Levied

11.11.9. Corporate Tax Structure

11.11.10. Investments

11.11.11. Major Companies

11.12. China Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

11.13. China Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

11.14. China Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

11.15. China Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

11.16. China Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

11.17. India Market

11.18. India Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

11.19. India Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

11.20. India Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

11.21. India Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

11.22. India Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

11.23. Japan Market

11.24. Japan Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

11.25. Japan Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

11.26. Japan Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

11.27. Japan Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

11.28. Japan Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

11.29. Australia Market

11.30. Australia Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

11.31. Australia Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

11.32. Australia Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

11.33. Australia Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

11.34. Australia Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

11.35. Indonesia Market

11.36. Indonesia Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

11.37. Indonesia Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

11.38. Indonesia Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

11.39. Indonesia Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

11.40. South Korea Market

11.41. South Korea Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

11.42. South Korea Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

11.43. South Korea Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

11.44. South Korea Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

11.45. South Korea Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

12. Western Europe Market

12.1. Summary

12.2. Market Overview

12.2.1. Region Information

12.2.2. Market Information

12.2.3. Background Information

12.2.4. Government Initiatives

12.2.5. Regulations

12.2.6. Regulatory Bodies

12.2.7. Major Associations

12.2.8. Taxes Levied

12.2.9. Corporate Tax Structure

12.2.10. Investments

12.2.11. Major Companies

12.3. Western Europe Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

12.4. Western Europe Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

12.5. Western Europe Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

12.6. Western Europe Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

12.7. Western Europe Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

12.8. Western Europe Gene Therapy Market: Country Analysis

12.9. UK Market

12.10. UK Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

12.11. UK Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

12.12. UK Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

12.13. UK Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

12.14. UK Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

12.15. Germany Market

12.16. Germany Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

12.17. Germany Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

12.18. Germany Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

12.19. Germany Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

12.20. Germany Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

12.21. France Market

12.22. France Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

12.23. France Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

12.24. France Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

12.25. France Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

12.26. France Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

13. Eastern Europe Market

13.1. Summary

13.2. Market Overview

13.2.1. Region Information

13.2.2. Market Information

13.2.3. Background Information

13.2.4. Government Initiatives

13.2.5. Regulations

13.2.6. Regulatory Bodies

13.2.7. Major Associations

13.2.8. Taxes Levied

13.2.9. Corporate Tax Structure

13.2.10. Investments

13.2.11. Major Companies

13.3. Eastern Europe Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

13.4. Eastern Europe Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

13.5. Eastern Europe Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

13.6. Eastern Europe Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

13.7. Eastern Europe Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

13.8. Eastern Europe Gene Therapy Market: Country Analysis

13.9. Russia Market

13.10. Russia Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

13.11. Russia Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

13.12. Russia Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

13.13. Russia Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

13.14. Russia Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

14. North America Market

14.1. Summary

14.2. Market Overview

14.2.1. Region Information

14.2.2. Market Information

14.2.3. Background Information

14.2.4. Government Initiatives

14.2.5. Regulations

14.2.6. Regulatory Bodies

14.2.7. Major Associations

14.2.8. Taxes Levied

14.2.9. Corporate Tax Structure

14.2.10. Investments

14.2.11. Major Companies

14.3. North America Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

14.4. North America Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

14.5. North America Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

14.6. North America Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

14.7. North America Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

14.8. North America Gene Therapy Market: Country Analysis

14.9. USA Market

14.10. Summary

14.11. Market Overview

14.11.1. Country Information

14.11.2. Market Information

14.11.3. Background Information

14.11.4. Government Initiatives

14.11.5. Regulations

14.11.6. Regulatory Bodies

14.11.7. Major Associations

14.11.8. Taxes Levied

14.11.9. Corporate Tax Structure

14.11.10. Investments

14.11.11. Major Companies

14.12. USA Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

14.13. USA Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

14.14. USA Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

14.15. USA Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

14.16. USA Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

15. South America Market

15.1. Summary

15.2. Market Overview

15.2.1. Region Information

15.2.2. Market Information

15.2.3. Background Information

15.2.4. Government Initiatives

15.2.5. Regulations

15.2.6. Regulatory Bodies

15.2.7. Major Associations

15.2.8. Taxes Levied

15.2.9. Corporate Tax Structure

15.2.10. Investments

15.2.11. Major Companies

15.3. South America Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

15.4. South America Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

15.5. South America Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

15.6. South America Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

15.7. South America Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

15.8. South America Gene Therapy Market: Country Analysis

15.9. Brazil Market

15.10. Brazil Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

15.11. Brazil Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

15.12. Brazil Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

15.13. Brazil Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

15.14. Brazil Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

16. Middle East Market

16.1. Summary

16.2. Market Overview

16.2.1. Region Information

16.2.2. Market Information

16.2.3. Background Information

16.2.4. Government Initiatives

16.2.5. Regulations

16.2.6. Regulatory Bodies

16.2.7. Major Associations

16.2.8. Taxes Levied

16.2.9. Corporate Tax Structure

16.2.10. Investments

16.2.11. Major Companies

16.3. Middle East Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

16.4. Middle East Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

16.5. Middle East Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

16.6. Middle East Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

16.7. Middle East Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

17. Africa Market

17.1. Summary

17.2. Market Overview

17.2.1. Region Information

17.2.2. Market Information

17.2.3. Background Information

17.2.4. Government Initiatives

17.2.5. Regulations

17.2.6. Regulatory Bodies

17.2.7. Major Associations

17.2.8. Taxes Levied

17.2.9. Corporate Tax Structure

17.2.10. Investments

17.2.11. Major Companies

17.3. Africa Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million)

17.4. Africa Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

17.5. Africa Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

17.6. Africa Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

17.7. Africa Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)

18. Competitive Landscape and Company Profiles

18.1. Company Profiles

18.2. Novartis AG

18.2.1. Company Overview

18.2.2. Products And Services

18.2.3. Business Strategy

18.2.4. Financial Overview

18.3. F. Hoffmann-La Roche AG

18.3.1. Company Overview

18.3.2. Products And Services

18.3.3. Business Strategy

18.3.4. Financial Overview

18.4. Gilead Sciences Inc.

18.4.1. Company Overview

18.4.2. Products And Services

18.4.3. Financial Overview

18.5. Astellas Pharma Inc.

18.5.1. Company Overview

18.5.2. Products And Services

18.5.3. Business Strategy

18.5.4. Financial Overview

18.6. Biogen Inc.

18.6.1. Company Overview

18.6.2. Products And Services

18.6.3. Business Strategy

18.6.4. Financial Overview

19. Key Mergers And Acquisitions

19.1. Rocket Pharmaceuticals Acquired Renovacor

19.2. Eli Lilly Acquired Akouos

19.3. Ginkgo Bioworks Acquired Altar and Circularis

19.4. Solvias Acquired Cergentis

19.5. Novartis Acquired Gyroscope Therapeutics

19.6. FHI Clinical Acquired Triclinium Clinical Development

19.7. WuXi AppTec Acquired OXGENE

20. Pipeline Analysis

20.1. Products In Development

20.2. Approved Products

21. Opportunities And Strategies

21.1. Global Gene Therapy Market In 2027 – Countries Offering Most New Opportunities

21.2. Global Gene Therapy Market In 2027 – Segments Offering Most New Opportunities

21.3. Global Gene Therapy Market In 2027 – Growth Strategies

21.3.1. Market Trend Based Strategies

21.3.2. Competitor Strategies

22. Gene Therapy Market, Conclusions And Recommendations

22.1. Conclusions

22.2. Recommendations

22.2.1. Product

22.2.2. Place

22.2.3. Price

22.2.4. Promotion

22.2.5. People

23. Appendix

23.1. Market Data Sources

23.2. Research Methodology

23.3. Currencies

23.4. The Business Research Company

23.5. Copyright and Disclaimer

List Of Tables

Table 1: Global Gene Therapy Market, Historic, 2017 – 2022, $ Million

Table 2: Global Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million

Table 3: Global Gene Therapy Market, Segmentation By Gene Therapy Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Table 4: Global Gene Therapy Market, Segmentation By Gene Therapy Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million

Table 5: Global Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Table 6: Global Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million

Table 7: Global Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Table 8: Global Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million

Table 9: Global Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Table 10: Global Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million

Table 11: Global Gene Therapy Market, By Region, Historic and Forecast, 2017 – 2022, 2027F, 2032F, %

Table 12: Global Gene Therapy Market, By Region, Historic and Forecast, 2017 – 2022, 2027F, 2032F, $ Million

Table 13: Global Gene Therapy Market, By Country, Historic and Forecast, 2017 – 2022, 2027F, 2032F, %

Table 14: Global Gene Therapy Market, By Country, Historic and Forecast, 2017 – 2022, 2027F, 2032F, $ Million

Table 15: Asia-Pacific GDP Per Capita, By Country, 2017-2022, $

Table 16: Asia-Pacific Population, By Country, 2017-2027, Millions

Table 17: Asia-Pacific, Pharmaceuticals Market Size, By Country, 2017-2027, $ Billion

Table 18: Asia-Pacific Gene Therapy Market, Historic, 2017 – 2022, $ Million

Table 19: Asia-Pacific Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million

Table 20: Asia-Pacific Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Table 21: Asia-Pacific Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million

Table 22: Asia-Pacific Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Table 23: Asia-Pacific Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million

Table 24: Asia-Pacific Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Table 25: Asia-Pacific Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million

Table 26: China GDP Per Capita, 2017-2022, $

Table 27: China Population, 2017-2027, Millions

Table 28: China Pharmaceuticals Market Size, 2017-2027, $ Billion

Table 29: China Gene Therapy Market, Historic, 2017 – 2022, $ Million

Table 30: China Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million

Table 31: China Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Table 32: China Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million

Table 33: China Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Table 34: China Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million

Table 35: China Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Table 36: China Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million

Table 37: India Gene Therapy Market, Historic, 2017 – 2022, $ Million

Table 38: India Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million

Table 39: India Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Table 40: India Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million

Table 41: India Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Table 42: India Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million

Table 43: India Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Table 44: India Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million

Table 45: Japan Gene Therapy Market, Historic, 2017 – 2022, $ Million

Table 46: Japan Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million

Table 47: Japan Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Table 48: Japan Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million

Table 49: Japan Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Table 50: Japan Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million

Table 51: Japan Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Table 52: Japan Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million

Table 53: Australia Gene Therapy Market, Historic, 2017 – 2022, $ Million

Table 54: Australia Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million

Table 55: Australia Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Table 56: Australia Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million

Table 57: Australia Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Table 58: Australia Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million

Table 59: Australia Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Table 60: Australia Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million

Table 61: Indonesia Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million

Table 62: Indonesia Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Table 63: Indonesia Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million

Table 64: Indonesia Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Table 65: Indonesia Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million

Table 66: Indonesia Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Table 67: Indonesia Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million

Table 68: South Korea Gene Therapy Market, Historic, 2017 – 2022, $ Million

Table 69: South Korea Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million

Table 70: South Korea Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Table 71: South Korea Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million

Table 72: South Korea Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Table 73: South Korea Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million

Table 74: South Korea Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Table 75: South Korea Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million

Table 76: Western Europe GDP Per Capita, By Country, 2017-2022, $

Table 77: Western Europe Population, By Country, 2017-2027, Millions

Table 78: Western Europe Pharmaceuticals Market Size, By Country, 2017-2027, $ Billion

Table 79: Western Europe Gene Therapy Market, Historic, 2017 – 2022, $ Million

Table 80: Western Europe Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million

Table 81: Western Europe Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Table 82: Western Europe Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million

Table 83: Western Europe Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Table 84: Western Europe Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million

Table 85: Western Europe Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Table 86: Western Europe Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million

Table 87: UK Gene Therapy Market, Historic, 2017 – 2022, $ Million

Table 88: UK Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million

Table 89: UK Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Table 90: UK Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million

Table 91: UK Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Table 92: UK Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million

Table 93: UK Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Table 94: UK Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million

Table 95: Germany Gene Therapy Market, Historic, 2017 – 2022, $ Million

Table 96: Germany Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million

Table 97: Germany Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Table 98: Germany Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million

Table 99: Germany Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Table 100: Germany Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million

Table 101: Germany Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Table 102: Germany Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million

Table 103: France Gene Therapy Market, Historic, 2017 – 2022, $ Million

Table 104: France Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million

Table 105: France Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Table 106: France Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million

Table 107: France Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Table 108: France Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million

Table 109: France Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Table 110: France Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million

Table 111: Eastern Europe GDP Per Capita, By Country, 2017-2022, $

Table 112: Eastern Europe Population, By Country, 2017-2027, Millions

Table 113: Eastern Europe Pharmaceuticals Market Size, By Country, 2017-2027, $ Billion

Table 114: Eastern Europe Gene Therapy Market, Historic, 2017 – 2022, $ Million

Table 115: Eastern Europe Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million

Table 116: Eastern Europe Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Table 117: Eastern Europe Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million

Table 118: Eastern Europe Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Table 119: Eastern Europe Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million

Table 120: Eastern Europe Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Table 121: Eastern Europe Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million

Table 122: Russia Gene Therapy Market, Historic, 2017 – 2022, $ Million

Table 123: Russia Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million

Table 124: Russia Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Table 125: Russia Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million

Table 126: Russia Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Table 127: Russia Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million

Table 128: Russia Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Table 129: Russia Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million

Table 130: North America GDP Per Capita, By Country, 2017-2022, $

Table 131: North America Population, By Country, 2017-2027, Millions

Table 132: North America Pharmaceuticals Market Size, By Country, 2017-2027, $ Billion

Table 133: North America Gene Therapy Market, Historic, 2017 – 2022, $ Million

Table 134: North America Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million

Table 135: North America Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Table 136: North America Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million

Table 137: North America Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Table 138: North America Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million

Table 139: North America Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Table 140: North America Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million

Table 141: USA GDP Per Capita, 2017-2022, $

Table 142: USA Population, 2017-2027, Millions

Table 143: USA Pharmaceuticals Market Size, 2017-2027, $ Billion

Table 144: USA Gene Therapy Market, Historic, 2017 – 2022, $ Million

Table 145: USA Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million

Table 146: USA Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Table 147: USA Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million

Table 148: USA Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Table 149: USA Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million

Table 150: USA Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Table 151: USA Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million

Table 152: South America GDP Per Capita, By Country, 2017-2022, $

Table 153: South America Population, By Country, 2017-2027, Millions

Table 154: South America Pharmaceuticals Market Size, By Country, 2017-2027, $ Billion

Table 155: South America Gene Therapy Market, Historic, 2017 – 2022, $ Million

Table 156: South America Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million

Table 157: South America Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Table 158: South America Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million

Table 159: South America Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Table 160: South America Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million

Table 161: South America Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Table 162: South America Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million

Table 163: Brazil Gene Therapy Market, Historic, 2017 – 2022, $ Million

Table 164: Brazil Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million

Table 165: Brazil Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Table 166: Brazil Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million

Table 167: Brazil Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Table 168: Brazil Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million

Table 169: Brazil Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Table 170: Brazil Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million

Table 171: Middle East GDP Per Capita, By Country, 2017-2022, $

Table 172: Middle East Population, By Country, 2017-2027, Millions

Table 173: Middle East Pharmaceuticals Market Size, By Country, 2017-2027, $ Billion

Table 174: Middle East Gene Therapy Market, Historic, 2017 – 2022, $ Million

Table 175: Middle East Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million

Table 176: Middle East Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Table 177: Middle East Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million

Table 178: Middle East Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Table 179: Middle East Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million

Table 180: Middle East Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Table 181: Middle East Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million

Table 182: Africa GDP Per Capita, By Country, 2017-2022, $

Table 183: Africa Population, By Country, 2017-2027, Millions

Table 184: Africa Pharmaceuticals Market Size, By Country, 2017-2027, $ Billion

Table 185: Africa Gene Therapy Market, Historic, 2017 – 2022, $ Million

Table 186: Africa Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million

Table 187: Africa Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Table 188: Africa Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million

Table 189: Africa Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Table 190: Africa Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million

Table 191: Africa Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Table 192: Africa Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, $ Million

Table 193: Global Gene Therapy Market, Key Competitor Estimated Market Shares, 2021, Percentage (%)

Table 194: Novartis – Financial Performance, 2017– 2021, $Billion

Table 195: Roche – Financial Performance, 2017– 2021, $Billion

Table 196: Gilead – Financial Performance, 2017– 2021, $Billion

Table 197: Astellas – Financial Performance, 2017– 2021, $Billion

Table 198: Biogen – Financial Performance, 2017– 2021, $Billion

Table 199: Global Gene Therapy Market, Pipeline Analysis

Table 200: Global Gene Therapy Market, Approved Products

Table 201: Global Gene Therapy Market Type Gain ($ Million), 2022 – 2027, By Country

Table 202: Global Gene Therapy Market Type Gain ($ Million), Segmentation By Gene Therapy Type, 2022 – 2027

Table 203: Global Gene Therapy Market Type Gain ($ Million), Segmentation By Vector, 2022 – 2027

Table 204: Global Gene Therapy Market Type Gain ($ Million), Segmentation By End Users, 2022 – 2027

Table 205: Global Gene Therapy Market Type Gain ($ Million), Segmentation By Application, 2022 – 2027

Table 206: Gene Therapy - Market Data Sources

List Of Figures

Figure 1: Geographic Regions Covered

Figure 2: Global Gene Therapy Market Segmentation By Gene Therapy Type

Figure 3: Global Gene Therapy Market Segmentation By Vector

Figure 4: Global Gene Therapy Market Segmentation By End Users

Figure 5: Global Gene Therapy Market Segmentation By Application

Figure 6: Global Gene Therapy Market, Historic, 2017 – 2022, $ Million

Figure 7: Global Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million

Figure 8: Global Gene Therapy Market, Segmentation By Gene Therapy Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Figure 9: Global Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Figure 10: Global Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Figure 11: Global Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Figure 12: Global Gene Therapy Market, By Region, Historic and Forecast, 2017 – 2022, 2027F, 2032F, %

Figure 13: Global Gene Therapy Market, By Country, Historic and Forecast, 2017 – 2022, 2027F, 2032F, %

Figure 14: Asia-Pacific Gene Therapy Market, Historic, 2017 – 2022, $ Million

Figure 15: Asia-Pacific Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million

Figure 16: Asia-Pacific Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Figure 17: Asia-Pacific Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Figure 18: Asia-Pacific Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Figure 19: China Gene Therapy Market, Historic, 2017 – 2022, $ Million

Figure 20: China Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million

Figure 21: China Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Figure 22: China Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Figure 23: China Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Figure 24: India Gene Therapy Market, Historic, 2017 – 2022, $ Million

Figure 25: India Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million

Figure 26: India Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Figure 27: India Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Figure 28: India Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Figure 29: Japan Gene Therapy Market, Historic, 2017 – 2022, $ Million

Figure 30: Japan Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million

Figure 31: Japan Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Figure 32: Japan Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Figure 33: Japan Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Figure 34: Australia Gene Therapy Market, Historic, 2017 – 2022, $ Million

Figure 35: Australia Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million

Figure 36: Australia Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Figure 37: Australia Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Figure 38: Australia Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Figure 39: Indonesia Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million

Figure 40: Indonesia Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Figure 41: Indonesia Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Figure 42: Indonesia Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Figure 43: South Korea Gene Therapy Market, Historic, 2017 – 2022, $ Million

Figure 44: South Korea Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million

Figure 45: South Korea Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Figure 46: South Korea Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Figure 47: South Korea Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Figure 48: Western Europe Gene Therapy Market, Historic, 2017 – 2022, $ Million

Figure 49: Western Europe Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million

Figure 50: Western Europe Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Figure 51: Western Europe Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Figure 52: Western Europe Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Figure 53: UK Gene Therapy Market, Historic, 2017 – 2022, $ Million

Figure 54: UK Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million

Figure 55: UK Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Figure 56: UK Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Figure 57: UK Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Figure 58: Germany Gene Therapy Market, Historic, 2017 – 2022, $ Million

Figure 59: Germany Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million

Figure 60: Germany Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Figure 61: Germany Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Figure 62: Germany Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Figure 63: France Gene Therapy Market, Historic, 2017 – 2022, $ Million

Figure 64: France Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million

Figure 65: France Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Figure 66: France Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Figure 67: France Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Figure 68: Eastern Europe Gene Therapy Market, Historic, 2017 – 2022, $ Million

Figure 69: Eastern Europe Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million

Figure 70: Eastern Europe Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Figure 71: Eastern Europe Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Figure 72: Eastern Europe Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Figure 73: Russia Gene Therapy Market, Historic, 2017 – 2022, $ Million

Figure 74: Russia Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million

Figure 75: Russia Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Figure 76: Russia Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Figure 77: Russia Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Figure 78: North America Gene Therapy Market, Historic, 2017 – 2022, $ Million

Figure 79: North America Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million

Figure 80: North America Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Figure 81: North America Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Figure 82: North America Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Figure 83: USA Gene Therapy Market, Historic, 2017 – 2022, $ Million

Figure 84: USA Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million

Figure 85: USA Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Figure 86: USA Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Figure 87: USA Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Figure 88: South America Gene Therapy Market, Historic, 2017 – 2022, $ Million

Figure 89: South America Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million

Figure 90: South America Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Figure 91: South America Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Figure 92: South America Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Figure 93: Brazil Gene Therapy Market, Historic, 2017 – 2022, $ Million

Figure 94: Brazil Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million

Figure 95: Brazil Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Figure 96: Brazil Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Figure 97: Brazil Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Figure 98: Middle East Gene Therapy Market, Historic, 2017 – 2022, $ Million

Figure 99: Middle East Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million

Figure 100: Middle East Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Figure 101: Middle East Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Figure 102: Middle East Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Figure 103: Africa Gene Therapy Market, Historic, 2017 – 2022, $ Million

Figure 104: Africa Gene Therapy Market, Forecast, 2022 – 2027, 2032F, $ Million

Figure 105: Africa Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Figure 106: Africa Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Figure 107: Africa Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, %

Figure 108: Global Gene Therapy Market, Key Competitor Estimated Market Shares, 2021, Percentage (%)

Figure 109: Novartis – Financial Performance, 2017– 2021, $Billion

Figure 110: Roche – Financial Performance, 2017– 2021, $Billion

Figure 111: Gilead – Financial Performance, 2017– 2021, $Billion

Figure 112: Astellas – Financial Performance, 2017– 2021, $Billion

Figure 113: Biogen – Financial Performance, $Billion

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

The Plasma Fractionation Market Share, Market Size, And Growth Rate 2022

The Biosimilar Therapeutic Peptides Market Share, Market Size, And Growth Rate 2022

Global Anticoagulants Market 2022 – Market Opportunities And Strategies

Latest Digestive Health Supplements Market Growth Study 2022-2026 By The Business Research Company

The Business Research Company offers the nucleic acid based gene therapy market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the radiopharmaceuticals market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the pegfilgrastim biosimilars market market research report 2022 with industry size, share, segments and market growth

CAR-T Therapy Market 2021 - By Target Antigen (CD19, CD22, BCMA), By Application (Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma), And By Region, Opportunities And Strategies – Global Forecast To 2030

View Report

Central Nervous System Drugs Market 2021 - By Type (Multiple Sclerosis (MS), Anti-Psychotic, Analgesics, Anti-Parkinson Drugs, Anesthetics, Anti-Epileptics, Anti-Depressants, Other CNS Drugs), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies/ Drug Stores), By Route Of Administration (Oral, Intravenous, Intranasal/ Inhalation), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Over-The-Counter Drugs, Prescription-Based Drugs), And By Region, Opportunities And Strategies – Global Forecast To 2030

View Report

Digestive Enzymes Global Market Report 2024 – By Enzyme Type (Carbohydrates, Protease, Lipase, Other Enzyme Types), By Origin (Animal, Fungi, Microbial, Plant), By Application (Indigestion, Chronic Pancreatitis, Irritable Bowel Syndrome, Other Applications), By Distribution Channel (Retail Stores, Online Stores) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Oncology Biosimilars Global Market Report 2024 – By Drug Type (Monoclonal Antibody, Immunomodulators, Hematopoietic Agents, Granulocyte Colony-Stimulating Factor (G-CSF)), By Cancer Type (Breast Cancer, Colorectal Cancer, Blood Cancer, Neutropenia Cancer, Non-Small Cell Lung Cancer, Other Cancer Types), By Distribution Type (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Interferons Global Market Report 2024 – By Type (Interferon Alpha, Interferon Beta, Interferon Gamma), By Application (Hepatitis B, Hepatitis C, Melanoma, Leukemia, Multiple Sclerosis, Renal Cell Carcinoma), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Corticosteroids Global Market Report 2024 – By Product (Glucocorticoids, Mineralocorticoids), By Application (Skin Allergies, Rheumatology Indications, Endocrinology, Acute Respiratory Diseases, Other Applications), By End User (Hospitals, Clinics, Research Institutes, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Monoclonal Antibodies (MAs) Global Market Report 2024 – By Source (Murine, Chimeric, Humanized, Human), By Application (Anti-Cancer, Immunological, Anti-Infective Monoclonal Antibodies (MAs), Neuropharmacological, Cardiovascular And Cerebrovascular, Other Applications), By End Users (Hospitals, Private Clinics, Research Institute) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Therapeutic Proteins Global Market Report 2024 – By Product Type (Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, Follicle Stimulating Hormone), By Function (Enzymatic and Regulatory Activity, Special Targeting Activity, Vaccines, Protein Diagnostics), By Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Frequently Asked Questions

What is the definition of the gene therapy market?

Gene therapy refers to a method for treating or curing sickness that alters a person's DNA. Gene treatments can function in a variety of ways: putting a healthy copy of the gene in place of a disease-causing gene, and putting a defective gene that causes an illness inactive. For further insights on the gene therapy market, request a sample here

How will the gene therapy market drivers and restraints affect the gene therapy market dynamics? What forces will shape the gene therapy industry going forward?

The gene therapy market growth is aided by increasing incidences of cancer and other target diseases. However, some gene therapy market restraints include high prices of gene therapy medicines. For further insights on the gene therapy market, request a sample here

What is the forecast market size or the forecast market value of the gene therapy market?

The gene therapy market is expected to reach $24.03 billion in 2027 at a rate of 26.4%. For further insights on the gene therapy market, request a sample here

How is the gene therapy market segmented?

The global gene therapy market is segmented as
1) By Gene Type: Antigen, Cytokine, Suicide Gene, Other Gene types
2) By Vector: Viral Vector, Non-Viral Vector, Other Vectors
3) By Application: Oncological Disorders, Rare Diseases, Cardiovascular Diseases, Neurological Disorders, Infectious Diseases, Other Applications
4) By End Users: Hospitals, Homecare, Specialty Clinics, Other End-Users
For further insights on the gene therapy market, request a sample here

Which region has the largest share of the gene therapy market? What are the largest region's market size and growth rate?

North America was the largest region in the gene therapy market in 2022. For detailed insights on the largest region's market size and growth rate, request a sample here.

Who are the major players in the gene therapy market?

Key competitors in the gene therapy market are, Novartis AG, Bluebird Bio, Inc., Spark Therapeutics, Inc., Audentes Therapeutics, Voyager Therapeutics, Applied Genetic Technologies Corporation, UniQure N.V., Celgene Corporation, Cellectis S.A., Sangamo Therapeutics, Gilead Lifesciences, Inc., Orchard Therapeutics, Sibiono GeneTech Co., Ltd., Gensight Biologics S.A., Shanghai Sunway Biotech Co., Ltd., Biogen, Sarepta Therapeutics, Inc., Sangamo Therapeutics, Audentes Therapeutics, Regenxbio, Inc., Gegenxbio, Inc, Oxford BioMedica plc., Dimension Therapeutics, Inc., Bristol-Myers Suibb Company, Sanofi, Taxus Cardium Pharmaceuticals Group, Inc. (Gene Biotherapeutics), Shrine Plc, Benitech Biopharma, Transgene, Epeius Biotechnologies Corp., Calimmune, Inc. For further insights on the gene therapy market, request a sample here.

What are the key trends in the gene therapy market?

Major trends influencing the gene therapy market include use of machine learning and artificial intelligence. Artificial intelligence (AI) is the simulation of human intelligence in machines, which are programmed to display their natural intelligence. Machine learning is a part of AI. Machine learning and AI help companies in the gene therapy market conduct a detailed analysis of all relevant data, provide insights between tumour and immune cell interactions, and offer a more accurate evaluation of tissue samples, which is often disputed between different evaluators. For further insights on the gene therapy market, request a sample here.

What are the major opportunities in the gene therapy market? What are the strategies for the gene therapy market?

For detailed insights on the major opportunities and strategies in the gene therapy market, request a sample here.

How does the gene therapy market relate to the overall economy and other similar markets?

For detailed insights on gene therapy market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the gene therapy industry?

For detailed insights on the mergers and acquisitions in the gene therapy industry, request a sample here.

What are the key dynamics influencing the gene therapy market growth? SWOT analysis of the gene therapy market.

For detailed insights on the key dynamics influencing the gene therapy market growth and SWOT analysis of the gene therapy industry, request a sample here.